FMfc-Family Medicine- Female Challenges is organized by American Medical Seminars (AMS), Inc. This course has been approved for a maximum of 5 AMA PRA Category 1 Credits™.
Original Release Date: July 1, 2021
Expiration Date: July 1, 2024
TOPIC 1: Abnormal Uterine Bleeding
Upon completion of this session, using ACOG Practice Guidelines, the participant should be able to: GL, COMP
• Define abnormal uterine bleeding.
• Differentiate between functional and organic causes.
• Manage most non-surgical etiologies of this problem.
TOPIC 2: Premenstrual Syndrome.
Upon completion of this session, using ACOG Guidelines and NIH Guidelines, the participant should be able to: GL, COMP
• Correctly diagnose patients with this disorder using NIH guidelines.
• Utilize current effective and FDA-approved therapies.
• Formulate an appropriate differential diagnosis for PMS.
TOPIC 3: Pelvic Pain.
Upon completion of this session, using ACOG Practice Guidelines, International Pelvic Pain Society (IPPS), and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP
• Assess the patient with acute or chronic pain.
• Identify the differential diagnosis and choose appropriate management options for the patient.
• Differentiate patients who require immediate attention to their pelvic pain versus the chronic pain patient.
If you’re unable to attend the conference you booked with American Medical Seminars, we hope you’ll consider transferring your registration to a different conference. However, if you do need to cancel, we offer the best cancellation policy of any CME conference company! Cancel for ANY reason prior to the first day of the conference and we will refund 100% of your registration fee.
Refunds for International Attendees - If American Medical Seminars issued you an Invitation Letter to attend a CME conference in the United States and you need to cancel your registration, your refund will be for $150 less than your registration fee. This is to cover the cost of your Invitation Letter.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved